2m 2m 2m 2m 2m 2m 2m
Innoviva (INVA)
NASDAQ
$21.70+$0.34 (+1.62%)
Price as of Jun 03, 2026 5:18 PM EDT- $1.6BMarket Cap
- 3.64%1-Year Change
- BiotechnologyIndustry
Innoviva (INVA)
$21.70+$0.34 (+1.62%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 236.5M -34.08% | 358.7M +15.54% | 310.5M -6.30% | 331.3M -15.45% | |
Cost of Revenue | 0 -100.00% | 1.4M -50.00% | 2.8M -79.70% | 13.8M N/A | |
Gross Profit | 307.7M -13.89% | 357.3M +16.14% | 307.7M -3.11% | 317.5M -18.97% | |
Sales and Marketing Expense | 113.3M -2.05% | 115.7M +17.77% | 98.2M +54.60% | 63.5M N/A | |
Research and Development Expense | -30.6M +124.14% | -13.7M -59.75% | -33.9M -18.13% | -41.4M +7,093.06% | |
Depreciation and Amortization Expense | 26.3M +1.45% | 25.9M +18.90% | 21.8M +290.32% | 5.6M -59.65% | |
Total Operating Expenses | 143.9M -55.21% | 321.3M +176.13% | 116.4M +162.14% | 44.4M +164.81% | |
Operating Profit | 163.7M +337.96% | 37.4M -80.74% | 194.1M -32.36% | 286.9M -23.50% | |
Interest Income | 21.1M +10.16% | 19.1M +21.01% | 15.8M +148.36% | 6.4M +246.33% | |
Interest Expense | -16.7M -24.81% | -22.2M +15.93% | -19.2M +21.33% | -15.8M -17.21% | |
Interest Income and Expense and Net | 4.4M +243.02% | -3.1M -8.12% | -3.3M -64.55% | -9.4M -45.33% | |
Total Nonoperating Income and Expense | -2.9M -4.44% | -3.0M -39.69% | -5.0M +47.32% | -3.4M -6.98% | |
Income before Taxes | 326.9M +774.24% | 37.4M -80.74% | 194.1M -32.36% | 286.9M -35.56% | |
Income Taxes | 55.7M +297.95% | 14.0M -2.64% | 14.4M -78.44% | 66.7M -12.76% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 271.2M +1,059.22% | 23.4M -86.98% | 179.7M -18.41% | 220.3M -40.28% | |
Net Income from Continuing Operations Applicable to Common | 326.9M +1,297.32% | 23.4M -86.98% | 179.7M -15.99% | 213.9M -19.53% | |
Basic EPS and Net Income | 4.02 +986.49% | 0.37 -86.55% | 2.75 -10.42% | 3.07 -5.25% | |
Diluted EPS and Net Income | 3.30 +816.67% | 0.36 -83.64% | 2.20 -7.17% | 2.37 -17.42% | |
Basic Weighted Average Shares | 67.4M +7.44% | 62.7M -4.14% | 65.4M -6.04% | 69.6M -15.13% | |
Diluted Weighted Average Shares | 84.8M +14.25% | 74.2M -14.61% | 86.9M -8.79% | 95.2M +0.99% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 550.9M +80.66% | 305.0M +57.59% | 193.5M -33.51% | 291.0M +44.42% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 550.9M +80.66% | 305.0M +57.59% | 193.5M -33.51% | 291.0M +44.42% | |
Total Current Assets | 727.5M +31.25% | 554.3M +61.03% | 344.2M -22.39% | 443.5M +41.39% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.6M +202.53% | 514,000 +6.42% | 483,000 +184.12% | 170,000 +1,316.67% | |
Total Long-Term Assets | 40.7M -1.77% | 41.5M +1,169.57% | 3.3M -24.01% | 4.3M +3,880.56% | |
Total Assets | 1.6B +25.68% | 1.3B +4.63% | 1.2B +0.98% | 1.2B +32.93% | |
Income Taxes Payable | 89.1M +67.36% | 53.2M +9,354.17% | 563,000 -90.50% | 5.9M N/A | |
Total Short-Term Debt | 0 -100.00% | 192.0M N/A | 0 -100.00% | 96.2M N/A | |
Total Current Liabilities | 49.7M -78.95% | 236.1M +519.09% | 38.1M -71.75% | 135.0M +2,224.23% | |
Total Long-Term Debt | 257.7M +0.55% | 256.3M -42.56% | 446.2M +0.46% | 444.2M +12.55% | |
Total Long-Term Liabilities | 66.1M +2.83% | 64.3M -10.57% | 71.9M +1.34% | 70.9M N/A | |
Total Liabilities | 49.7M -78.95% | 236.1M +519.09% | 38.1M -71.75% | 135.0M +2,224.23% | |
Retained Earnings | 269.4M +15,089.87% | -1.8M -92.87% | -25.2M -87.71% | -204.9M -55.08% | |
Total Stockholders Equity | 1.2B +69.69% | 691.2M +2.40% | 675.0M +19.29% | 565.8M +36.42% | |
Total Shares Outstanding | 74.6M +19.10% | 62.7M -1.01% | 63.3M -8.50% | 69.2M -0.54% | |
Cash Flow | |||||
Cash from Operating Activities | 196.9M +4.37% | 188.7M +33.76% | 141.1M -30.07% | 201.7M -44.55% | |
Capital Expenditures | 1.1M +318.89% | 270,000 -34.31% | 411,000 +513.43% | 67,000 N/A | |
Cash from Investing Activities | 40.5M +163.49% | -63.8M -4.46% | -66.8M +17.88% | -56.6M -229.53% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.6M +163.56% | -13.5M -92.17% | -171.8M +209.24% | -55.6M -87.72% | |
Financials Ratio | |||||
Gross Margin | 100.00% +0.39% | 99.61% +0.52% | 99.10% +3.40% | 95.84% N/A | |
Operating Margin | 69.24% +564.33% | 10.42% -83.33% | 62.52% -27.81% | 86.60% -9.53% | |
Return on Assets | 18.47% +904.59% | 1.84% -87.34% | 14.52% -28.86% | 20.41% -46.70% | |
Return on Equity | 29.10% +749.59% | 3.42% -88.18% | 28.97% -35.52% | 44.93% -41.86% | |
Revenue Growth | -34.08% -319.26% | 15.54% +346.66% | -6.30% -59.21% | -15.45% -194.46% | |
Current Ratio | 14.64 +523.51% | 2.35 -73.99% | 9.03 +174.70% | 3.29 -93.92% | |
Cash Ratio | 11.09 +758.20% | 1.29 -74.54% | 5.07 +135.33% | 2.16 -93.79% | |
Debt-to-Equity Ratio | 0.22 -66.13% | 0.65 -1.88% | 0.66 -30.78% | 0.96 N/A | |
Debt-to-Assets Ratio | 0.16 -54.27% | 0.34 -3.98% | 0.36 -18.21% | 0.44 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow